Get Access
TreelipClinical Program Risk Radar
Oncology Phase 2Methodology
NCT01524926

CREATE: Cross-tumoral Phase 2 With Crizotinib

Public trial-level signal summary for this oncology Phase 2 record.

Back to reportOpen ClinicalTrials.gov
Record overview

Status and phase

Status: COMPLETED

Phase: PHASE2

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Condition: Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma, Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor, Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1, Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma, Locally Advanced and/or Metastatic Clear Cell Sarcoma, Locally Advanced and/or Metastatic Alveolar Rhabdomyosarcoma

Signal summary

Public flags

Status signal: Low Signal

Timeline signals: stale_update_signal

Results signal: Completed No Results Found Signal

Operational burden: large_enrollment_target_signal | strict_eligibility_signal

Stopped reason

Context when available

No stop reason available in the current public record.